Axitinib Impurity 29
- CAS1639138-00-3
- CatalogueRS-A105009
- FormulaC17H14IN3O2S
- MW451.28
BACK ORDER
On this page
Product identification
| Product name | Axitinib Impurity 29 |
|---|---|
| Catalogue No. | RS-A105009 |
| CAS No. | 1639138-00-3 |
| Molecular formula | C17H14IN3O2S |
| Molecular weight | 451.28 |
| Availability | Back order— restocking can be arranged, about 1–2 weeks |
| Standard type | Impurity Reference Standards |
| Drug substance | Axitinib |
| Also known as | Axitinib Impurity 11 |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-A105009 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
A certificate of analysis (COA) is issued for the lot you receive. It records the catalogue number
RS-A105009 and the batch number, the tests performed, the
specification applied and the result obtained. A safety data sheet is supplied with the shipment.
Is the assigned value given on an “as is” basis?
Content and purity are stated per lot on the certificate of analysis, on an “as is” basis unless the certificate says otherwise. The analytical basis for the assigned value is stated on the certificate.
How should this material be stored?
Store as stated: Refer to the certificate of analysis (COA) supplied with each lot. Re-test before use beyond the retest date printed on the certificate.
Do you supply pack sizes other than those listed?
Pack sizes are confirmed with the quotation. Quantities beyond the standard pack sizes can be quoted — send the quantity you need with your enquiry.
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Axitinib
- Impurity Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-A105009
- Request a quotation for RS-A105009
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Axitinib
All 83 further standards are listed here — every link is in the page, not loaded later.
-
Axitinib
IN STOCKRS-U059320 -
Axitinib Impurity B
IN STOCKRS-A105034 -
Axitinib Impurity F
IN STOCKRS-A105006 -
Axitinib Impurity H
IN STOCKRS-A105008 -
(E)-6-Iodo-3-(2-(pyridin-2-yl)vinyl)-1H-indazole
IN STOCKRS-U047134 -
(Z)-Axitinib
IN STOCKRS-A105014 -
1-(tetrahydro-2H-pyran-2-yl)-6-nitro-1H-indazole
BACK ORDERRS-U016947 -
1H-Indazol-6-ol
BACK ORDERRS-U015928 -
Thimerosal USP Related Compound A
CUSTOM SYNTHESISRS-P006250 -
Axitinib EP Impurity D
IN STOCKRS-P018415 -
2-(Methylthio)phenacyl Bromide
IN STOCKRS-U053145 -
2-[(2-Carbamoylphenyl)disulfanyl]benzamide
IN STOCKRS-P001913 -
2-Amino-4-nitrotoluene
IN STOCKRS-U002390 -
2-Hydroxy-N-methylbenzamide
IN STOCKRS-U067510 -
2-mercaptobenzoic acid
IN STOCKRS-C001033 -
2-Methylbenzo[d]isothiazol-3(2H)-one
CUSTOM SYNTHESISRS-A002141 -
3,6-Diiodo-1H-indazole
IN STOCKRS-P006438 -
3-Mercapto-N-methylbenzamide
IN STOCKRS-U211OMA -
4-Hydroxyindazole
BACK ORDERRS-U067877 -
5-Chloro-1,2-benzisothiazol-3(2H)-one
IN STOCKRS-U090121 -
6-Chloro-1H-indazole
IN STOCKRS-U063891 -
6-iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
BACK ORDERRS-U011433 -
6-Iodo-1H-indazole
IN STOCKRS-P031055 -
Axitinib Acid
IN STOCKRS-A105056 -
Axitinib Amide Impurity
IN STOCKRS-A105025 -
Axitinib des Iodo analog
IN STOCKRS-A105011 -
Axitinib Impurity N3
IN STOCKRS-A105054 -
Axitinib Sulfone Impurity
IN STOCKRS-A105002 -
Axitinib Sulfoxide
IN STOCKRS-A105001 -
Axitinib Tetrahydro-2H-pyran
IN STOCKRS-U059522 -
Axitinib-13C-d3 (1261432-00-1)
IN STOCKRS-A105046 -
Axitinib-d3
IN STOCKRS-A105015 -
Dehydro Axitinib
CUSTOM SYNTHESISRS-A105023 -
N-Methylnitrous Amide
IN STOCKRS-A105027 -
o-mercapto-N,N-dimethylbenzamide
BACK ORDERRS-U086329 -
Axitinib dimer Impurity 1
BACK ORDERRS-A105017 -
Axitinib Impurity 2
BACK ORDERRS-A105003 -
Axitinib Impurity 3
IN STOCKRS-A105016 -
Axitinib Impurity 12
IN STOCKRS-A105010 -
Axitinib Impurity 20
BACK ORDERRS-I001929 -
Axitinib Impurity 22
BACK ORDERRS-I001BHF -
Axitinib Impurity 34
BACK ORDERRS-A105055 -
Axitinib Impurity 49
IN STOCKRS-A105030 -
Axitinib Impurity 57
BACK ORDERRS-I001ANR -
Axitinib Impurity 58
IN STOCKRS-A105049 -
Axitinib Impurity 61
BACK ORDERRS-I001ALF -
Axitinib Impurity 67
CUSTOM SYNTHESISRS-A105020 -
Axitinib Impurity 81
BACK ORDERRS-I001A8Z -
Axitinib Impurity 82
IN STOCKRS-A105051 -
Axitinib Impurity 85
CUSTOM SYNTHESISRS-A105036 -
Axitinib Impurity 90
IN STOCKRS-I001ALO -
Axitinib Impurity 91
IN STOCKRS-A105052 -
Axitinib Impurity 96
IN STOCKRS-A105041 -
Axitinib Impurity 97
BACK ORDERRS-A105053 -
Axitinib Impurity 99
IN STOCKRS-A105021 -
Axitinib Impurity 110
IN STOCKRS-A105045 -
Axitinib Impurity 113
IN STOCKRS-A105038 -
Axitinib Impurity 114
IN STOCKRS-A105037 -
Axitinib Impurity 115
IN STOCKRS-A105035 -
Axitinib Impurity 116
IN STOCKRS-A105043 -
Axitinib Impurity 118
CUSTOM SYNTHESISRS-A105044 -
Axitinib Impurity 119
CUSTOM SYNTHESISRS-A105039 -
Axitinib Impurity 120
IN STOCKRS-A105040 -
Axitinib Impurity 122
CUSTOM SYNTHESISRS-A105005 -
Axitinib Impurity 124
BACK ORDERRS-A105013 -
Axitinib Impurity 125
IN STOCKRS-A105024 -
Axitinib Impurity 126
IN STOCKRS-A105026 -
Axitinib Impurity 127
IN STOCKRS-A105031 -
Axitinib Impurity 128
IN STOCKRS-A105033 -
Axitinib Impurity 129
CUSTOM SYNTHESISRS-A105050 -
Axitinib Impurity 150
IN STOCKRS-A105004 -
Axitinib Impurity 151
IN STOCKRS-A105012 -
Axitinib Impurity 152
BACK ORDERRS-A105018 -
Axitinib Impurity 153
IN STOCKRS-A105019 -
Axitinib Impurity 154
IN STOCKRS-A105022 -
Axitinib Impurity 155
IN STOCKRS-A105028 -
Axitinib Impurity 156
IN STOCKRS-A105029 -
Axitinib Impurity 157
IN STOCKRS-A105032 -
Axitinib Impurity 158
IN STOCKRS-A105042 -
Axitinib Impurity 194
IN STOCKRS-A105047 -
Axitinib Impurity 195
IN STOCKRS-A105048 -
Axitinib Impurity 196
BACK ORDERRS-A105057
![Chemical structure of (E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole](/structures/w4/QXJFRDDGGSSQDX-CSKARUKUSA-N.webp?v=9)
![Chemical structure of 2-[(2-Carbamoylphenyl)disulfanyl]benzamide](/structures/w4/OEEHSSKRJOGQMP-UHFFFAOYSA-N.webp?v=9)
![Chemical structure of 2-Methylbenzo[d]isothiazol-3(2H)-one](/structures/w4/RDWXSJCICPOOKO-UHFFFAOYSA-N.webp?v=9)
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.